Male Menopause Is Getting Serious Medical Attention—And the Market Is Booming

Male menopause, also called andropause, is finally getting mainstream medical recognition. The global market for treating this condition is valued at USD 1.39 billion in 2025 and is projected to reach USD 3.46 billion by 2035, growing at a rate of 9.7% annually. This expansion reflects a fundamental shift: men are increasingly seeking help for symptoms like fatigue, mood changes, low libido, and muscle loss caused by declining testosterone levels as they age.

What Exactly Is Male Menopause, and Why Is It Getting More Attention?

Male menopause, or andropause, happens when testosterone levels gradually decline with age. Unlike female menopause, which occurs relatively quickly, this process unfolds slowly over years. Men experiencing andropause often report mood swings, depression, erectile dysfunction, exhaustion, decreased muscle mass, and bone loss. For decades, these symptoms were either ignored or attributed to other causes, but growing awareness is changing that narrative.

The shift toward recognizing andropause stems from several factors. Media coverage, digital health platforms, and proactive healthcare initiatives have reduced the stigma surrounding men's hormonal health. Men are now more willing to have open conversations about symptoms that were once considered taboo, which has expanded the patient base seeking diagnosis and treatment.

How Are Doctors Treating Male Menopause Today?

The treatment landscape for andropause includes multiple approaches, each addressing different aspects of the condition:

• Testosterone Replacement Therapy (TRT): This is the dominant treatment method, accounting for the largest market share in 2025. TRT works by restoring hormone levels to a normal range and can be delivered through injections, gels, patches, or pellets. Advances in formulation technology have made these options more patient-friendly and improved adherence to treatment.
• Cognitive Behavioral Therapy (CBT): This psychological approach is the fastest-growing segment of the male menopause treatment market. CBT uses structured intervention models to manage hormonally-related anxiety, irritability, sleep disturbance, and motivation loss. It has strong clinical validation and is now more accessible through digital mental health services and telehealth platforms.
• Alternative Medicine Options: The market also includes acupuncture, herbal supplements, and homeopathy as complementary approaches to symptom management.
• Psychological Counseling: Beyond CBT, this category includes stress reduction programs and support groups designed to help men navigate the emotional and cognitive changes associated with andropause.

The diversity of treatment options reflects a broader shift toward personalized medicine. Healthcare providers are increasingly tailoring therapies to each patient's specific needs and genetic profile, which improves outcomes and patient satisfaction.

What's Driving the Explosive Growth in This Market?

Several interconnected factors are fueling the rapid expansion of the male menopause treatment market. First, there's the demographic reality: the global population is aging, particularly in developed and rising nations. More aging men means more men experiencing andropause symptoms and seeking treatment.

Second, lifestyle-related health problems are making the situation more urgent. Rising rates of diabetes and obesity can worsen hormonal imbalances and lead to secondary hypogonadism (low testosterone caused by underlying health conditions), which requires medical intervention. These conditions create a larger patient population in need of treatment.

Third, diagnostic technology has improved dramatically. Advanced blood testing and biomarker analysis now allow doctors to detect testosterone insufficiency earlier and more accurately. This enables proactive treatment before symptoms become severe. Better diagnostics naturally lead to more diagnoses and more patients entering the treatment pipeline.

Finally, pharmaceutical companies are investing heavily in research and development for male health issues. This pipeline of novel treatments and innovative delivery methods—such as oral formulations, transdermal patches, and long-acting injectables—is improving treatment effectiveness and patient adherence, which further drives market growth.

Are There Safety Concerns Holding Back Treatment?

Despite the market's growth, significant concerns about testosterone replacement therapy persist. Clinical research and regulatory warnings have highlighted potential risks associated with long-term TRT use, including cardiovascular problems, prostate issues, and hormonal abnormalities. These safety concerns have prompted many countries to tighten prescribing policies and increase regulatory oversight, which may limit widespread adoption in some regions.

Additionally, the need for continuous monitoring—including frequent blood tests and medical supervision—raises treatment costs and may discourage some patients from starting or continuing therapy. Inconsistent insurance coverage in certain areas and patient anxiety about side effects further reduce treatment accessibility and compliance.

Where Is This Market Growing Fastest?

North America dominated the male menopause treatment market in 2025, driven by several advantages. The region has a sophisticated healthcare system, considerable disposable income, and a strong cultural emphasis on men's wellness and preventative healthcare. This combination makes treatments more widely available and more affordable for patients.

North America also benefits from strong clinical research capabilities that encourage innovation and a well-established regulatory framework that facilitates the approval and marketing of new medications. Importantly, the region has integrated wellness initiatives, mental health services, and endocrinology into holistic treatment pathways that address emotional, cognitive, and physical aspects of andropause simultaneously. Strong reimbursement coverage for counseling and psychological services further supports this comprehensive approach.

As awareness of andropause continues to grow and treatment options expand, the male menopause market is poised for sustained growth. The shift away from stigma and toward evidence-based, personalized care represents a significant step forward in men's health—one that acknowledges that hormonal changes in aging men deserve the same medical attention and compassionate care as any other health condition.